Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

36 results about "Chronic radiation enteropathy" patented technology

Nausea, vomiting, fatigue and diarrhea may happen early during the course of radiotherapy. Radiation enteropathy represents the longer-term, chronic effects which may be found after a latent period most commonly of 6 months to 3 years after the end of treatment.

Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders

ActiveUS20100093720A1BiocidePeptide/protein ingredientsGastrointestinal dysmotilityStress induced
The present invention provides conformationally-defined macrocyclic compounds that bind to and / or are functional modulators of the motilin receptor including subtypes, isoforms and / or variants thereof. These macrocyclic compounds, at a minimum, possess adequate pharmacological properties to be useful as therapeutics for a range of disease indications. In particular, these compounds are useful for treatment and prevention of disorders characterized by hypermotilinemia and / or gastrointestinal hypermotility, including, but not limited to, diarrhea, cancer treatment-related diarrhea, cancer-induced diarrhea, chemotherapy-induced diarrhea, radiation enteritis, radiation-induced diarrhea, stress-induced diarrhea, chronic diarrhea, AIDS-related diarrhea, C. difficile associated diarrhea, traveller's diarrhea, diarrhea induced by graph versus host disease, other types of diarrhea, dyspepsia, irritable bowel syndrome, chemotherapy-induced nausea and vomiting (emesis) and post-operative nausea and vomiting and functional gastrointestinal disorders. In addition, the compounds possess utility for the treatment of diseases and disorders characterized by poor stomach or intestinal absorption, such as short bowel syndrome, celiac disease and cachexia. The compounds also have use for the treatment of inflammatory diseases and disorders of the gastrointestinal tract, such as inflammatory bowel disease, ulcerative colitis, Crohn's disease and pancreatitis. Accordingly, methods of treating such disorders and pharmaceutical compositions including compounds of the present invention are also provided.
Owner:OCERA THERAPEUTICS INC

Transgenic mesenchyma stem cell for curing radiation enteritis and method of producing the same

The invention discloses a transgenic mesenchymal stem cell which can treat radiation enteritis and a preparation method. The CXCR4 protein can be expressed highly on the surface of transgenic mesenchymal stem cell; under the chemotaxis of stromal cell derived factor which is released from the injured intestine, the homing and colonization of a large amount of transgenic mesenchymal stem cells can promote proliferation and repair of the intestinal mucosa and inhibit apoptosis; the radiation enteritis is cured. The steps of the preparation method of the transgenic mesenchymal stem cell are that : (1)the separation and cultivation of mesenchymal stem cell; (2) the preparation of CXCR4 recombinant adenovirus: full length cDNA of CXCR4 is amplified by RT-PCR; the construction of CXCR4 recombinant shuttle plasmid and skeleton plasmid; the CXCR4 recombinant adenovirus is packaged, amplified, purified and determined by titer in HEK293T cell; (3) the transfect ion of mesenchymal stem cell by using CXCR4 recombinant adenovirus.
Owner:NANJING UNIV

Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex

The present invention relates to novel conformationally-defined macrocyclic compounds that bind to and / or are functional modulators of the motilin receptor including subtypes, isoforms and / or variants thereof. These macrocyclic compounds are useful as therapeutics for a range of gastrointestinal disorders, in particular those in which suppression or inhibition of the migrating motor complex (MMC) is effective or malfunction of gastric motility or increased motilin secretion is observed, such as hypermotilinemia, imitable bowel syndrome, dyspepsia, including gallbladder dyspepsia, diarrhea, cancer treatment-related diarrhea, cancer-induced diarrhea, chemotherapy-induced diarrhea, radiation enteritis, radiation-induced diarrhea, stress-induced diarrhea, chronic diarrhea, AIDS-related diarrhea, C. difficile associated diarrhea, traveller's diarrhea, acute infectious diarrhea, diarrhea induced by graph versus host disease, other types of diarrhea, functional gastrointestinal disorders, chemotherapy-induced nausea and vomiting (emesis), post-operative nausea and vomiting, cyclic vomiting syndrome and functional vomiting. Accordingly, methods of treating such disorders with such macrocyclic compounds and pharmaceutical compositions thereof are also provided in addition to methods of modulating the migrating motor complex.
Owner:TRANZYME PHARMA INC

Method for producing amniotic mesenchymal stromal cell composition, method for cryopreserving the same, and therapeutic agent

An object of the present invention is to provide a method for producing a mesenchymal stromal cell composition, comprising conveniently and aseptically separating high-purity amnion-derived MSCs by performing enzyme treatment only once. According to the present invention, the following are provided: a method for producing a mesenchymal stromal cell composition, comprising: performing enzyme treatment of an amnion with collagenase and thermolysis and / or dispase; and filtering the enzyme-treated amnion through a mesh; a method for producing a cryopreserved mesenchymal stromal cell composition; and a therapeutic agent comprising as an active ingredient the mesenchymal stromal cell composition for a disease selected from graft-versus-host disease, inflammatory bowel disease, systemic lupus erythematosus, liver cirrhosis, or radiation enteritis.
Owner:NAT CEREBRAL & CARDIOVASCULAR CENT +4

Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders

ActiveUS9133235B2BiocidePeptide/protein ingredientsGastrointestinal dysmotilityPharmacometrics
The present invention provides conformationally-defined macrocyclic compounds that bind to and / or are functional modulators of the motilin receptor including subtypes, isoforms and / or variants thereof. These macrocyclic compounds, at a minimum, possess adequate pharmacological properties to be useful as therapeutics for a range of disease indications. In particular, these compounds are useful for treatment and prevention of disorders characterized by hypermotilinemia and / or gastrointestinal hypermotility, including, but not limited to, diarrhea, cancer treatment-related diarrhea, cancer-induced diarrhea, chemotherapy-induced diarrhea, radiation enteritis, radiation-induced diarrhea, stress-induced diarrhea, chronic diarrhea, AIDS-related diarrhea, C. difficile associated diarrhea, traveller's diarrhea, diarrhea induced by graph versus host disease, other types of diarrhea, dyspepsia, irritable bowel syndrome, chemotherapy-induced nausea and vomiting (emesis) and post-operative nausea and vomiting and functional gastrointestinal disorders. In addition, the compounds possess utility for the treatment of diseases and disorders characterized by poor stomach or intestinal absorption, such as short bowel syndrome, celiac disease and cachexia. The compounds also have use for the treatment of inflammatory diseases and disorders of the gastrointestinal tract, such as inflammatory bowel disease, ulcerative colitis, Crohn's disease and pancreatitis. Accordingly, methods of treating such disorders and pharmaceutical compositions including compounds of the present invention are also provided.
Owner:OCERA THERAPEUTICS INC

Chinese medicinal preparation used for treating radiation enteritis

The invention relates to a Chinese medicinal preparation used for treating radiation enteritis. The Chinese medicinal preparation used for treating the radiation enteritis comprises the following effective raw material components: all-grass of broadleaf ainslaea, humifuse euphorbia herb, melastoma dodecandrum, calamint, lotus petiole, gynostemma pentaphyllum, chinese amphibious knotweed rhizome, meadowrue root and rhizome, gray polypody, sea-buckthorn, clematis finetiana, cactus, polygonum hydropiper, sago seed, fortune paulownia flower and screwtree root. The Chinese medicinal preparation used for treating the radiation enteritis has the effects of tonifying qi, nourishing yin, removing heat to promote salivation, astringe intestine to stop bleeding and astringing to stop pain and has a good treatment effect on radiation enteritis caused by a radioactive factor; the selected medicinal raw materials are available; the Chinese medicinal preparation used for treating the radiation enteritis is easy to make, low in cost and obvious in curative effect, can treat both symptoms and root causes and has no toxic and side effect; dialectical treatment is carried out according to a clinical disease, and the total effective rate of treatment on the radiation enteritis can be up to 98%.
Owner:梁付奎

Composition for improving or treating radiation enteritis and preparation method and application thereof

The invention belongs to the technical field of traditional Chinese medicines, and relates to a composition for improving or treating radiation enteritis and a preparation method and application thereof. The medicine composition for improving or treating radiation enteritis is prepared from the following crude drugs in parts by weight: 12 to 18 parts of purslane herb, 8 to 12 parts of flos sophorae immaturus, 8 to 12 parts of dark plum fruit, 2 to 5 parts of cinnamomum cassia, 12 to 18 parts of fructus hippophae, 2 to 6 parts of endothelium corneum gigeriae galli, and 8 to 12 parts of poria cocos. The composition has the advantages that the effect of treating the radiation enteritis is realized; the radiation enteritis symptoms due to radiotherapy in pelvic cavity and perineum, such as diarrhea and abdominal pain, mucous bloody stool and tenesmus, can be greatly relieved; the composition is suitable for patients with radiation enteritis to take in the period of chemoradiotherapy; especially, when the composition is prepared into the traditional Chinese medicine solid beverages, the preparing is convenient, the mouth feel is good, and the preparation technology is simple.
Owner:四川仙鹤生物技术有限公司

Application of propylene glycol to medicine for preventing intestinal type radiation disease and radiation enteritis

The invention provides application of propylene glycol to medicine for preventing intestinal type radiation disease and radiation enteritis. According to the application disclosed by the invention, the propylene glycol is firstly applied to the field of radiation protection research, and the research proves that compared with former prevention application, the propylene glycol has an obvious experimental therapeutic effect on acute radiation injury of intestinal tracts and has curative effects on intraperitoneal injection and oral administration; moreover, a radiation protection mechanism of the propylene glycol is possibly related with removal of hydroxyl radicals through the propylene glycol and alleviation of intestinal cell DNA injuries. At present, the phenomenon that gastrointestinaltissue injuries or the radiation enteritis occurs when the propylene glycol is applied to prevention of ionizing radiation or tumor radiotherapy is not reported yet.
Owner:ACADEMY OF MILITARY MEDICAL SCI

Method for establishing animal model of radiation-induced colorectal inflammation

The present invention provides a method for establishing an animal model of radiation-induced colorectal inflammation. The method comprises the following steps: mice are randomly divided into two large groups; the mice are normal fed for 1-2 weeks to enable the mice to be adapted to a new living environment; body positions of the mice during irradiation are simulated and an average value is taken;a radiotherapy plan is developed; depending on different group designs, a single large dose radiation is conducted using different doses of gradient rays; and severity of colorectal tissue lesions isassessed. Combining clinical practices, a common therapeutic ray (6MV X ray) used by a medical linear accelerator can better simulate radioactive colorectal injury lesion process of clinical radiotherapy side reactions, and besides, the method is low in animal mortality and simple and easy to repeat, provides an experimental basis for studying the radioactive colorectal injury, is convenient forfurther studying mechanism of the radioactive colorectal injury and guiding clinical medication, closer to clinical practice and more conducive to studying course mechanism of radiation enteritis anddrug development, and can also further expand use of a prevention and treatment technology applied in the radiation enteritis.
Owner:NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV

Medicine for treating radiation enteritis and preparation method and application of medicine

The invention discloses a medicine for treating radiation enteritis and a preparation method and application of the medicine. The medicine is composed of the following raw materials including, by weight, 3-7 parts of levamisole, 11-19 parts of bromhexine, 5-13 parts of taurine and 1-5 parts of calcium pyruvate. The levamisole, the bromhexine and the calcium pyruvate are mixed and added into deionized water, and the mixture is heated to 75 DEG C to 77 DEG C and stirred for 38 min to 40 min to prepare the mixture A; the mixture A and the taurine are mixed and subjected to ultrasonic treatment at 58 DEG C for 25 min, the ultrasonic power is 900W, then the mixture is stirred to dry at 63 DEG C, and the medicine is obtained. The medicine has the advantages of being unique in formula, low in price, safe and convenient to use, the effect of the medicine is superior to that of conventionally used western medicines, the medicine can effectively cure the junction and rectal injuries caused during radiotherapy and is high in cure rate, quick in effect and free of toxic and side effects and relapse after curing, simple in preparation process, short in production cycle low in cost and suitable for industrial production and large-scale popularization, and the raw materials are simple and easy to obtain.
Owner:郑州莉迪亚医药科技有限公司

Use of small intestine SP cells in preparing medicament for treating damage of intestines

The invention discloses a new application of alvine SP cells, which is the application of alvine SP cells in the preparation of medicament for treating alvine injury. In the invention, alvine SP cells are in-situ implanted to a whole abdominal cavity exposed mouse, and the experiment proves that SP cells can return to alvine crypts to repair the injury, and also can prolong the surviving time of the animal model exposed by lethal dose, obviously improve the chronic fibrosis of radiation enteritis, and achieve nice repair effect on radiation alvine injury. The invention provides an innovative and convenient method and means for the clinic therapy of alvine injury diseases, and lays a foundation for seeking specific surface markings for stem cells of alvine mucous membrane.
Owner:何东南 +3

Composition treating colorectal cancer and applications of medicines treating colorectal cancer

The invention discloses a composition treating colorectal cancer and applications of medicines treating colorectal cancer. The composition comprises the following ingredients containing treatment effective doses: any one or two of ground beetle and gekko swinhonis seu japonicus, any one or two of peach seeds and curcuma rhizome, any one or two of radix sophorae flavescentis and patrinia herb, any one or two of smilax glabra and cortex moutan, any one or two of garden burnet and barbat skullcap, any one or two of sophora flowers and pseudobulubs cremastrae seu pleiones, and any one or two of dandelion and manyleaf paris rhizome. The composition is provided in an ingredient ratio less than a poisonous dose. The composition also can comprise coix seeds or radix scrophulariae, and is used combined with chemotherapeutants further. The composition is suitable for colorectal cancer patients with current known various symptoms, can inhibit precancerous lesions effectively, improves mucous bloody stool of intestinal cancer patients, relieves radiation enteritis, raises life quality of intestinal cancer patients and provides a forward life expectancy with definite and objective therapeutic effects for intestinal cancer patients.
Owner:林丽珠

Application of CXCL16 protein and its monoclonal antibody in preparation of drugs to prevent and/or treat intestinal injuries

The invention provides application of CXCL16 protein and its monoclonal antibody in the preparation of drugs to prevent and / or treat intestinal injuries, and also provides a molecular marker to predict or / and diagnose severity of radiation enteritis. The molecular marker is CXCL16 protein, having an amino acid sequence shown as SEQ NO. 1. It is discovered through a series of human sample and animal experimental verifications that a monoclonal antibody of CXCL16 can prevent and relieve radiation intestinal injury and fibrosis effectively and has a good clinical application prospect. The severity of radiation enteritis in a patient can be judged herein by detecting expression level of CXCL15 mRNA in peripheral serum of the patient; judging is simple and fast; patient compliance is good, and the cost is low.
Owner:THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIV

Traditional Chinese medicine composition for treating radiation enteritis and preparation method of traditional Chinese medicine composition

InactiveCN110772568AFunction increaseStrengthen the effect of thickening the intestines and stopping dysenteryDigestive systemPlant ingredientsLiver and kidneyLicorice roots
The invention discloses a traditional Chinese medicine composition for treating radiation enteritis. The traditional Chinese medicine composition is prepared from herb of shiny cinquefoil, radix scutellariae, ashgrey loosestrife herb, fructus forsythiae, fructus aurantii, radix aucklandiae, scorzonera subacaulis and licorice roots. The invention also discloses a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is reasonable in component compatibility, can clear heat, promote diuresis, promote qi circulation, relieve pain, calm theliver and regulate qi, has no obvious liver and kidney toxicity, and is suitable for being applied to radiation enteritis treatment.
Owner:QINGDAO CENT HOSPITAL

Application of PDGF inhibitor in preparation of medicines for treating intestinal inflammation diseases

The invention belongs to the field of biological medicine, and relates to application of a PDGF inhibitor in preparation of medicines for treating intestinal inflammation diseases, in particular to application of a PDGFR signal pathway inhibitor in preparation of medicines for treating radiation enteritis. It is found for the first time that both ligands and receptors of PDGFR signal pathways arehighly expressed in intestinal tissues with radiation enteritis. Furthermore, intestinal injuries caused by radiotherapy are effectively relieved by inhibiting the PDGFR signal pathways. The inventionprovides a brand-new idea for treating radiation enteritis.
Owner:THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIV

Medicine for treating radiation enteritis, and preparation method and application thereof

The invention discloses a medicine for treating radiation enteritis and a preparation method thereof. The medicine is composed of the following raw materials in parts by weight: 3-7 parts of rabeprazole, 11-19 parts of radix astragali extract, 5-13 parts of taurine and 1-5 parts of calcium pyruvate. The preparation method comprises the following steps: mixing the rabeprazole, radix astragali extract and calcium pyruvate, adding deionized water, heating to 75-77 DEG C, and stirring for 38-40 minutes to obtain a mixture A; mixing the mixture A with the taurine, carrying out ultrasonic treatment at 58 DEG C under the ultrasonic power of 900W for 25 minutes, and stirring at 63 DEG C to a dry state, thereby obtaining the medicine. The medicine for treating radiation enteritis has the characteristics of unique composition and low price, is safe and convenient, and has better effects than the conventional western medicine. The medicine for treating radiation enteritis can effectively cure the colon and recta injuries caused by radiotherapy, and has the advantages of high cure rate, quick effect taking, no toxic or side effect, and no relapse after curing. The preparation method has the advantages of simple preparation technique, simple and accessible raw materials, short production cycle and low cost, and is suitable for industrial production and large-scale popularization.
Owner:ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD

Application of liriodendrin in medicine for treating radiation enteritis

PendingCN113456658AHas anti-inflammatory and anti-apoptotic effectsProtectiveOrganic active ingredientsAntipyreticNeurilemmaProinflammatory cytokine
The invention provides an application of liriodendrin in a medicine for treating radiation enteritis. The invention finds that the liriodendrin has anti-inflammatory and anti-apoptosis effects in radiation enteritis, and through nerve sphingolipid pathway detection, it is found that the liriodendrin can reduce the expression of Cer, Cer1P and S1P, which prompts that the liriodendrin has anti-inflammatory and anti-apoptosis effects on radiation enteritis, and the liriodendrin can inhibit the expression of proinflammatory cytokines (IL-6 and TNF-alpha) in the intestinal tract of a mouse with radiation enteritis. Besides, the liriodendrin can effectively inhibit expression of intestinal tissues p-NF-kB of mice suffering from radiation enteritis, and the liriodendrin can also reduce the number of neutrophils in the intestinal tissues, which shows that the liriodendrin has an anti-inflammatory effect in radiation enteritis. A theoretical basis is provided for deep research on pathogenesis of radiation enteritis and development of new drugs, so that a scientific basis is provided for clinical treatment of radiation enteritis by using liriodendrin, and a more beneficial treatment scheme can be provided for patients with radiation enteritis.
Owner:核工业四一六医院

Application of costus lactone and derivative thereof in preparation of medicine for preventing and/or treating intestinal injury

The invention provides application of costus lactone and a derivative thereof in preparation of a medicine for preventing and / or treating intestinal injury, and belongs to the technical field of chemical medicines. Specifically, the invention provides application of a compound shown as a formula I, or a salt thereof, or a stereoisomer thereof, or a solvate thereof, or a hydrate thereof, or a prodrug thereof in preparation of a medicine for preventing and / or treating intestinal injury, and R1 and R2 are respectively and independently selected from C1-C8 alkyl groups. Research finds that costus lactone has a protective effect on intestinal epithelial cell injury, especially radiation-induced intestinal epithelial cell injury, can effectively prevent and / or treat intestinal injury, especially radiation intestinal injury, especially radiation enteritis, can prolong the survival rate and improve the life quality of a patient, and has good safety within an effective dose. The costus lactone can be used for preparing medicines for preventing and / or treating intestinal injury, especially radioactive intestinal injury, and has a good application prospect.
Owner:成都医学院第一附属医院 +1

Traditional Chinese medicine enema used for treating radiation enteritis

The invention discloses a traditional Chinese medicine enema used for treating radiation enteritis. In traditional Chinese medical science, the radiation enteritis belongs to the categories of 'diarrhoea' and 'stomachache', and pathogenesis comprises deficient root with overdo superficial, pathogenic heat entering the interior and temperament depletion. Thus, traditional Chinese medicines with the effects of clearing away heat and toxic materials, tonifying deficiency and dehumidifying, stopping bleeding and eliminating inflammation and relieving diarrhea with astringents, such as clerodendrum fortunatum root, houttuynia cordata, japanese claw fern herb, souliea vaginata, golden cypress, white atractylodes rhizome, tortuous knotweed root, limonite, Japanese beauty-berry leaf, ferrugineous ask bark, crinis trachycarpi and liquorice are selected and prepared into the enema by a medicine preparation room of a hospital (described in the specification), clinical test shows that the total effective rate is 95.1% and is obviously better than that of a control group, and recovery time is shorter than that of the control group, so that the traditional Chinese medicine enema is worthy of clinical popularization and application.
Owner:武传华

Method for producing amniotic mesenchymal stromal cell composition, method for cryopreserving the same, and therapeutic agent

An object of the present invention is to provide a method for producing a mesenchymal stromal cell composition, comprising conveniently and aseptically separating high-purity amnion-derived MSCs by performing enzyme treatment only once. According to the present invention, the following are provided: a method for producing a mesenchymal stromal cell composition, comprising: performing enzyme treatment of an amnion with collagenase and thermolysin and / or dispase; and filtering the enzyme-treated amnion through a mesh; a method for producing a cryopreserved mesenchymal stromal cell composition; and a therapeutic agent comprising as an active ingredient the mesenchymal stromal cell composition for a disease selected from graft-versus-host disease, inflammatory bowel disease, systemic lupus erythematosus, liver cirrhosis, or radiation enteritis.
Owner:NAT CEREBRAL & CARDIOVASCULAR CENT +4

Medicament for treating radiation enteritis and preparation method thereof

The invention relates to a medicament for treating radiation enteritis. The medicament is prepared from the following raw materials: 20-30 parts of dangshen, 20-30 parts of lightyellow sophora root, 15-20 parts of fineleaf schizonepeta herb, 10-15 parts of baikal skullcap root, 10-15 parts of galangal-root, 5-10 parts of cortex eucommiae, 5-10 parts of clematis root, 5-10 parts of densefruit pittany root-bark and 5-10 parts of red paeony root. The medicament for treating radiation enteritis has remarkably better than the conventional medicament, has the advantages of quick response, short treatment of course, high economical efficiency, practicability, freeness from side effects, high curative rate and prevention of relapse, and is worthy of clinical popularization and application.
Owner:孙伟

Application of BMNP in protecting intestinal tract from ionizing radiation injury

The invention provides an application of BMNP in protecting intestinal tracts from ionizing radiation injury. Researches prove that the nanoparticle BMNP has a very good protection effect on radiation enteritis induced by ionizing radiation, can inhibit apoptosis and pyroptosis processes of intestinal cells in a manner of scavenging free radicals, and can protect intestinal stem cells from radiation damage, thereby maintaining intestinal homeostasis and functions.
Owner:中国人民解放军火箭军特色医学中心

Traditional Chinese medicine formula for treating radiation enteritis

The invention discloses a traditional Chinese medicine formula for treating radiation enteritis, and belongs to the field of traditional Chinese medicine. The formula consists of the following medicines in parts by weight: 15-20 parts of raw radix astragali, 8-12 parts of rhizoma atractylodis, 8-12 parts of white atractylodes rhizome, 25-30 parts of raw coix seed, 8-12 parts of processed endothelium corneum gigeriae galli, 12-18 parts of radix sophorae flavescentis, 12-18 parts of calcined fossil fragments, 1-2 parts of dragon's blood powder, 8-12 parts of parched white peony root and 5-10 parts of raw liquorice root. The formula can be used for treating intestinal mucosa hyperemia, edema and cell injury caused by ray radiation and improving subsequent symptoms such as abdominal pain, diarrhea, tenesmus, bloody purulent stool and the like; and the formula disclosed by the invention has functions of protecting liver and resisting tumor recurrence and transfer.
Owner:平鑫乐

Composition for treating colorectal cancer and use for preparing medicine for treating colorectal cancer

The invention discloses a composition treating colorectal cancer and applications of medicines treating colorectal cancer. The composition comprises the following ingredients containing treatment effective doses: any one or two of ground beetle and gekko swinhonis seu japonicus, any one or two of peach seeds and curcuma rhizome, any one or two of radix sophorae flavescentis and patrinia herb, any one or two of smilax glabra and cortex moutan, any one or two of garden burnet and barbat skullcap, any one or two of sophora flowers and pseudobulubs cremastrae seu pleiones, and any one or two of dandelion and manyleaf paris rhizome. The composition is provided in an ingredient ratio less than a poisonous dose. The composition also can comprise coix seeds or radix scrophulariae, and is used combined with chemotherapeutants further. The composition is suitable for colorectal cancer patients with current known various symptoms, can inhibit precancerous lesions effectively, improves mucous bloody stool of intestinal cancer patients, relieves radiation enteritis, raises life quality of intestinal cancer patients and provides a forward life expectancy with definite and objective therapeutic effects for intestinal cancer patients.
Owner:林丽珠

Application of KGF to preparation of drugs used for treating or preventing radiation enteritis

The invention relates to application of KGF to preparation of drugs used for treating or preventing radiation enteritis, belonging to the field of biological medicine. As KGF is applied to treatment or prevention of radiation enteritis, the symptoms of radiation enteritis can be eliminated or prevented, and intestinal injury caused by radioactive irradiation can be avoided, repaired and / or improved.
Owner:CHINA INST FOR RADIATION PROTECTION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products